Press Room

News / May 15, 2017

Hovione Cork receives Partnership Award

Hovione Cork receives Partnership Award at the CETB's Carrigaline Facility's 10 Year Anniversary

Hovione Cork receives Partnership Award | Hovione
Donnacha Ryan (Training Support Specialist, Hovione Cork) accepting a partnership award on behalf of Hovione Cork from Simon Coveney (Minister for Housing, Planning, Community and Local Government) and Ted Owens (CEO, Cork Education & Training Board) at the CETB'S Carrigaline Facility's 10 Year Anniversary
cetb and Cork Training Center logos | Hovione

During CETB's Carrigaline Facility's 10 Year Anniversary, Hovione Cork receives a Partnership Award from the Cork Training Center for the support Hovione Cork has provided to the Cork Training Center Biopharma facility in ensuring its facilities,  programmes  and learners continue to reflect the ongoing needs of the life sciences companies in the region.

 

Hovione Cork receives Partnership Award | Hovione
Donnacha Ryan (Training Support Specialist, Hovione Cork) with Valerie Cowman (Assistant Manager, Cork Education & Training Board Carrigaline)

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025